Table 1.
Required data elements for determining real-world time to treatment discontinuation (rwTTD) for a systemic anticancer therapy (SACT) drug in a specific line of therapy (LOT).
| Operational steps to ascertain rwTTD and type of data category | Commonly used data elements | |
| Identify records of the drug of interest | ||
|
|
SACT drug | Drug_name, NDCa, HCPCSb code, RxNorm code |
|
|
SACT administration | Drug administration datec |
|
|
SACT order | Drug order dated |
| Identify discontinuation date from subsequent LOT start date | ||
|
|
LOT | LOT namee |
|
|
LOT | LOT number |
|
|
LOT | LOT start date |
|
|
LOT | LOT end date |
| If no subsequent LOT, identify discontinuation date from patient death record during treatment | ||
|
|
Mortality status | Vital status or date of death |
| If no date of death, identify discontinuation date by last follow-up date subheading | ||
|
|
Last follow-up | Date of last follow-upf |
aNDC: National Drug Code.
bHCPCS: Healthcare Common Procedure Coding System.
cThe drug administration date is defined as the date of receiving medication at a health care facility as a medical service, often applicable to an intravenous drug.
dThe drug order date is defined as the order date for drugs used at home, often applicable to an oral drug.
eThe LOT name is determined by the combination of SACT drugs administered or ordered from the LOT start to end dates.
fThe date of last follow-up is defined as the last documented clinic visit or procedure in the electronic health record.